PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

about

A Nucleolar Stress-Specific p53-miR-101 Molecular Circuit Functions as an Intrinsic Tumor-Suppressor Network Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer

P2860

Q57700801-F129B1EC-13ED-4DE3-8E8C-33CB83908846 Q58567297-B90B98E6-4D30-4437-96E8-22952DE7B6E7

P2860

PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

Item

http://www.wikidata.org/entity/Q50552396

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

@en

PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

@nl

type

Item

label

PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

@en

PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

@nl

prefLabel

PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

@en

PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

@nl

P1476

PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

@en

P2093

Conor J Kearney

http://www.w3.org/2001/XMLSchema#string

John Silke

http://www.w3.org/2001/XMLSchema#string

Kelly M Ramsbottom

http://www.w3.org/2001/XMLSchema#string

P2860

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis

Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis

The blockade of immune checkpoints in cancer immunotherapy

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

PD-1 and its ligands in tolerance and immunity

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination

P2888

cdd.2017.94

P304

1705-1716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDD.2017.94

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Najoua Lalaoui

Jane Oliaro

Andrew J Freeman

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28665401

http://www.w3.org/2001/XMLSchema#string

P921

TNF

P932

5596429

http://www.w3.org/2001/XMLSchema#string

PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

about

P2860

P2860

PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932